Advertisement

Prognostic value of clusterin/apolipoprotein J in patients with reperfused ST-segment elevation myocardial infarction

Published:October 28, 2022DOI:https://doi.org/10.1016/j.ejim.2022.10.019
      Dear Editor,

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ibanez B.
        • James S.
        • Agewall S.
        • Antunes M.J.
        • Bucciarelli-Ducci C.
        • Bueno H.
        • et al.
        2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with st-segment elevation of the european society of cardiology (esc).
        Eur Heart J. 2018; 39: 119-177
        • Chandrashekhar Y.
        • Alexander T.
        • Mullasari A.
        • Kumbhani D.J.
        • Alam S.
        • Alexanderson E.
        • et al.
        Resource and infrastructure-appropriate management of st-segment elevation myocardial infarction in low- and middle-income countries.
        Circulation. 2020; 141: 2004-2025
        • Wyatt A.
        • Yerbury J.
        • Poon S.
        • Dabbs R.
        • Wilson M.
        Chapter 6: the chaperone action of clusterin and its putative role in quality control of extracellular protein folding.
        Adv Cancer Res. 2009; 104: 89-114
        • Rohne P.
        • Prochnow H.
        • Koch-Brandt C.
        The clu-files: disentanglement of a mystery.
        Biomol Concepts. 2016; 7: 1-15
        • Cubedo J.
        • Padró T.
        • Vilahur G.
        • Crea F.
        • Storey R.F.
        • Lopez Sendon J.L.
        • et al.
        Glycosylated apolipoprotein j in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
        Eur Heart J. 2022; 43: 153-163
        • Koller L.
        • Richter B.
        • Winter M.P.
        • Sulzgruber P.
        • Potolidis C.
        • Liebhart F.
        • et al.
        Clusterin/apolipoprotein j is independently associated with survival in patients with chronic heart failure.
        J Clin Lipidol. 2017; 11: 178-184
        • O'Gara P.T.
        • Kushner F.G.
        • Ascheim D.D.
        • Casey Jr., D.E.
        • Chung M.K.
        • de Lemos J.A.
        • et al.
        2013 accf/aha guideline for the management of st-elevation myocardial infarction: executive summary: a report of the american college of cardiology foundation/american heart association task force on practice guidelines.
        Circulation. 2013; 127: 529-555
        • Park S.
        • Mathis K.W.
        • Lee I.K.
        The physiological roles of apolipoprotein j/clusterin in metabolic and cardiovascular diseases.
        Rev Endocr Metab Disord. 2014; 15: 45-53
        • Pereira R.M.
        • Mekary R.A.
        • da Cruz
        • Rodrigues K.C.
        • Anaruma C.P.
        • Ropelle E.R.
        • da Silva A.S.R.
        • et al.
        Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes.
        Heart Fail Rev. 2018; 23: 123-129
        • Sposito A.C.
        • de Lima-Junior J.C.
        • Moura F.A.
        • Barreto J.
        • Bonilha I.
        • Santana M.
        • et al.
        Reciprocal multifaceted interaction between hdl (high-density lipoprotein) and myocardial infarction.
        Arterioscler Thromb Vasc Biol. 2019; 39: 1550-1564